May 2007
Volume 48, Issue 13
ARVO Annual Meeting Abstract  |   May 2007
Tubedown Suppression in Choroidal and Retinal Vasculature During Aging
Author Affiliations & Notes
  • H. Paradis
    Faculty of Medicine, Memorial Univ Newfoundland, St John's, Newfoundland, Canada
  • E. Miskiewicz
    Faculty of Medicine, Memorial Univ Newfoundland, St John's, Newfoundland, Canada
  • W. V. Good
    Smith Kettlewell Eye Research Institute, 2318 Filmore, San Francisco, California
  • H. E. Grossniklaus
    Department of Ophthalmology, Emory Eye Center, Atlanta, Georgia
  • R. L. Gendron
    Faculty of Medicine, Memorial Univ Newfoundland, St John's, Newfoundland, Canada
  • Footnotes
    Commercial Relationships H. Paradis, None; E. Miskiewicz, None; W.V. Good, None; H.E. Grossniklaus, None; R.L. Gendron, None.
  • Footnotes
    Support CIHR, CFI
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 40. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Paradis, E. Miskiewicz, W. V. Good, H. E. Grossniklaus, R. L. Gendron; Tubedown Suppression in Choroidal and Retinal Vasculature During Aging. Invest. Ophthalmol. Vis. Sci. 2007;48(13):40.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose:: During aging, vision loss is an important problem that greatly impacts upon the quality of life and the maintenance of functional autonomy. Blood vessel overgrowth contributes to retinopathy in age-related blinding eye diseases which are traumatic to patients and are major burdens to the health care system: Both diabetic retinopathy and age-related macular degeneration are the leading causes of blindness in western populations and in people over age 60, respectively. Both diseases involve either retinal and/or sub-retinal blood vessel overgrowth. New improved therapies are needed to prevent and treat age-related retinopathies. We have discovered Tubedown, a novel factor which is necessary for the maintenance of healthy retina by preventing retinal and sub-retinal blood vessel overgrowth. Moreover, diabetic patients with retinal blood vessel overgrowth show loss of Tubedown expression in retinal blood vessels. Choroidal and retinal neovascular lesions observed in a Tubedown knockdown mouse model increase in severity with prolonged length of time of suppression of Tubedown. Thus, we hypothesized that age-related loss of Tubedown expression may be a causative factor in development of age-related retinal and choroidal neovascularization.

Methods:: The expression of Tubedown in retinas of young, middle aged and old mice was assessed by immunohistochemistry and western blotting. Expression of retinal and choroidal Tubedown was also evaluated by immunohistochemistry in specimens of young, middle age and old human individuals.

Results:: Aging groups of mice show an age-related loss of retinal Tubedown expression. Expression of Tubedown was significantly decreased in older specimens of human retina in both choroidal and retinal vessels.

Conclusions:: Our work suggests that Tubedown loss in the aging retina may be an indicator and predisposing factor for age-related blinding eye diseases.

Keywords: aging • neovascularization • vascular cells 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.